Viz.ai, founded in 2016 by neurosurgeon Chris Mansi and David Golan, built the first FDA-cleared AI platform for stroke triage, scanning imaging for signs of large vessel occlusion and alerting the full care team simultaneously, compressing a process that traditionally moved sequentially through radiologists and specialists one at a time.
That care-coordination focus, alerting an entire stroke team at once rather than accelerating any single reader's diagnosis, shows in new 2026 clinical data presented at the American Heart Association's International Stroke Conference: a 44% reduction in door-in-door-out time for large-vessel-occlusion stroke patients being transferred to comprehensive stroke centers. The platform is now trusted by more than 2,000 hospitals across the US and was ranked the #1 AI-powered clinical decision support platform in the 2026 Black Book survey of 1,237 healthcare leaders.
Enterprise pricing is negotiated per hospital and requires a sales conversation. For a hospital or stroke center that wants an entire care team alerted simultaneously on time-critical imaging findings, rather than a diagnosis moving sequentially through each specialist, Viz.ai's care-coordination approach addresses that directly.
